GlaxoSmithKline Comet trial in Covid vaccine meets primary endpoint Read More
UK dividends calendar - next 7 days Read More
LONDON BROKER RATINGS: Capital & Counties and Shaftesbury get upgrades Read More
LONDON BROKER RATINGS: Bernstein downgrades IAG and Ryanair Read More
LONDON BROKER RATINGS: StanChart and Flutter upped to Buy; THG cut Read More
LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest Read More
IN BRIEF: GSK's ViiV Healthcare survey finds support for HIV regimen Read More
LONDON BROKER RATINGS: Shore Capital raises WPP to Buy from Hold Read More
EXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger Read More
TOP NEWS: GSK eyes steady annual payout after solid third quarter Read More
UK earnings, trading statements calendar - next 7 days Read More
LONDON BROKER RATINGS: UBS lifts Fresnillo; Jefferies says buy Drax Read More
PRESS: Private equity firms eye Glaxo's consumer unit - Bloomberg Read More
LONDON MARKET CLOSE: Stocks fall on weakening global growth outlook Read More
GlaxoSmithKline to base Consumer Healthcare arm in Weybridge, Surrey Read More
Novartis's Sandoz completes purchase of GSK's cephalosporin business Read More
LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight Read More
GSK's ViiV eyes another US green light for child HIV treatment Read More
TOP NEWS: GSK's ViiV posts positive three-year switch data for dovato Read More
